The Iga Nephropathy Foundation Of America Inc
Iga Nephropathy Foundation shows strong revenue growth and zero officer compensation across all filings.
EIN: 201155709 · Wall Township, NJ · NTEE: H124 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $2.6M |
| Total Expenses | $1.2M |
| Program Spending | 85% |
| Net Assets | $707K |
| Transparency Score | 92/100 |
Is The Iga Nephropathy Foundation Of America Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
The Iga Nephropathy Foundation Of America Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About The Iga Nephropathy Foundation Of America Inc
The Iga Nephropathy Foundation Of America Inc (EIN: 201155709) is a nonprofit organization based in Wall Township, NJ, classified under NTEE code H124. The organization reported total revenue of $2.6M and total assets of $2.7M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of The Iga Nephropathy Foundation Of America Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
The Iga Nephropathy Foundation Of America Inc is a mid-size nonprofit that has been operating for 16 years, with 12 years of IRS 990 filings on record (2011–2022). Revenue has grown at a compound annual rate of 38.6%.
Key Financial Metrics (2022)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.5M |
| Total Expenses | $1.2M |
| Surplus / Deficit | +$273K |
| Total Assets | $711K |
| Total Liabilities | $4K |
| Net Assets | $707K |
| Operating Margin | 18.6% |
| Debt-to-Asset Ratio | 0.6% |
| Months of Reserves | 7.1 months |
Financial Health Grade: A
In 2022, The Iga Nephropathy Foundation Of America Inc reported a surplus of $273K with revenue exceeding expenses, holds 7.1 months of operating reserves (strong position), has a debt-to-asset ratio of 0.6% (very low leverage).
Financial Trends
Over 12 years of filings (2011–2022), The Iga Nephropathy Foundation Of America Inc's revenue has grown at a compound annual growth rate (CAGR) of 38.6%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2022 | +132.1% | +294.2% | +63.3% |
| 2021 | +153.9% | +61.8% | +318.9% |
| 2020 | +76.3% | +56.5% | +147.1% |
| 2019 | +58.3% | +42.1% | +106.2% |
| 2018 | +7.0% | -3.1% | +33.3% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2010 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates The Iga Nephropathy Foundation Of America Inc with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, The Iga Nephropathy Foundation Of America Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2022)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $273K, with revenue exceeding expenses.
- Debt-to-asset ratio: 0.6%.
Executive Compensation Analysis
Executive compensation has consistently been reported as 0% across all available filings, indicating a volunteer-led organization. This suggests a high level of dedication from leadership and efficient use of funds directly for the mission.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for The Iga Nephropathy Foundation Of America Inc:
- Consistent 0% officer compensation across all filings, indicating volunteer leadership.
- Significant revenue growth from $89,225 in 2018 to $1,466,953 in 2022, demonstrating increasing support.
- Strong program spending ratio (estimated 85%), indicating efficient use of funds for its mission.
- Healthy asset growth, reaching $710,704 in 2022, providing financial stability.
- Consistent IRS 990 filing history over 12 periods, showing commitment to transparency.
Frequently Asked Questions about The Iga Nephropathy Foundation Of America Inc
Is The Iga Nephropathy Foundation Of America Inc a legitimate charity?
The Iga Nephropathy Foundation Of America Inc (EIN: 201155709) is a registered tax-exempt nonprofit based in New Jersey. Our AI analysis gives it a Mission Score of 92/100. It has 12 years of IRS 990 filings on record. Total revenue: $2.6M. No red flags identified. 5 strengths noted. Financial health grade: A.
How does The Iga Nephropathy Foundation Of America Inc spend its money?
The Iga Nephropathy Foundation Of America Inc directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to The Iga Nephropathy Foundation Of America Inc tax-deductible?
The Iga Nephropathy Foundation Of America Inc is registered as a tax-exempt nonprofit (EIN: 201155709). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of The Iga Nephropathy Foundation Of America Inc's spending goes to programs?
The Iga Nephropathy Foundation Of America Inc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does The Iga Nephropathy Foundation Of America Inc compare to similar nonprofits?
With a transparency score of 92/100 (Excellent), The Iga Nephropathy Foundation Of America Inc is above average for NTEE category H124 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is The Iga Nephropathy Foundation Of America Inc located?
The Iga Nephropathy Foundation Of America Inc is headquartered in Wall Township, New Jersey and files with the IRS under EIN 201155709. It is classified under NTEE code H124.
How many years of IRS 990 filings does The Iga Nephropathy Foundation Of America Inc have?
The Iga Nephropathy Foundation Of America Inc has 12 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $2.6M in total revenue.
Is The Iga Nephropathy Foundation Of America Inc a good charity?
Based on the available data, the Iga Nephropathy Foundation Of America Inc appears to be a good charity. It demonstrates strong program spending (estimated 85%), significant revenue growth, and a notable absence of officer compensation, indicating efficient use of funds and dedicated leadership.
How has the organization's revenue grown over time?
The organization has experienced substantial revenue growth, increasing from $89,225 in 2018 to $1,466,953 in 2022, and reaching a latest reported revenue of $2,588,671, indicating increasing public support.
What is the organization's approach to executive compensation?
The organization reports 0% officer compensation across all available filings, suggesting that its leadership is volunteer-based and not drawing salaries from the organization's funds.
Filing History
IRS 990 filing history for The Iga Nephropathy Foundation Of America Inc showing financial trends over 12 years of public records:
Over 12 years of IRS 990 filings (2011–2022), The Iga Nephropathy Foundation Of America Inc's revenue has grown by 3536.1%, moving from $40K to $1.5M. Total assets increased by 6872.5% over the same period, from $10K to $711K. Total functional expenses rose by 3948.4%, from $29K to $1.2M. In its most recent filing year (2022), The Iga Nephropathy Foundation Of America Inc reported a surplus of $273K, with revenue exceeding expenses. The organization holds $4K in liabilities against $711K in assets (debt-to-asset ratio: 0.6%), resulting in net assets of $707K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2022 | $1.5M | $1.2M | $711K | $4K | — | View 990 |
| 2021 | $632K | $303K | $435K | $0 | — | View 990 |
| 2020 | $249K | $187K | $104K | $0 | — | — |
| 2019 | $141K | $120K | $42K | $0 | — | View 990 |
| 2018 | $89K | $84K | $20K | $0 | — | View 990 |
| 2017 | $83K | $87K | $15K | $0 | — | View 990 |
| 2016 | $65K | $59K | $19K | $0 | — | View 990 |
| 2015 | $70K | $112K | $13K | $0 | — | View 990 |
| 2014 | $101K | $91K | $55K | $0 | — | View 990 |
| 2013 | $83K | $48K | $45K | $0 | — | View 990 |
| 2012 | $42K | $42K | $10K | $0 | — | View 990 |
| 2011 | $40K | $29K | $10K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2022: Revenue of $1.5M, expenses of $1.2M, and assets of $711K (revenue +132.1% year-over-year).
- 2021: Revenue of $632K, expenses of $303K, and assets of $435K (revenue +153.9% year-over-year).
- 2020: Revenue of $249K, expenses of $187K, and assets of $104K (revenue +76.3% year-over-year).
- 2019: Revenue of $141K, expenses of $120K, and assets of $42K (revenue +58.3% year-over-year).
- 2018: Revenue of $89K, expenses of $84K, and assets of $20K (revenue +7.0% year-over-year).
- 2017: Revenue of $83K, expenses of $87K, and assets of $15K (revenue +27.9% year-over-year).
- 2016: Revenue of $65K, expenses of $59K, and assets of $19K (revenue -7.2% year-over-year).
- 2015: Revenue of $70K, expenses of $112K, and assets of $13K (revenue -30.2% year-over-year).
- 2014: Revenue of $101K, expenses of $91K, and assets of $55K (revenue +21.4% year-over-year).
- 2013: Revenue of $83K, expenses of $48K, and assets of $45K (revenue +99.1% year-over-year).
- 2012: Revenue of $42K, expenses of $42K, and assets of $10K (revenue +3.2% year-over-year).
- 2011: Revenue of $40K, expenses of $29K, and assets of $10K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for The Iga Nephropathy Foundation Of America Inc:
Data Sources and Methodology
This transparency report for The Iga Nephropathy Foundation Of America Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.